Meet the new arrivals at Greentown Houston. Photo courtesy of Greentown Labs

Greentown Labs closed out the second quarter with the addition of 17 startups, and just over half are collaborating with the Houston location.

The technology represented by the new additions span the industries of energy, agriculture, and manufacturing, with a focus on carbon capture, electrical usage efficiency, and resource accessibility.

Carbon capture

Two of the newest Houston members, Capture6 and C-Quester, are also part of the Carbon2Value Initiative, a global partnership between the Greentown Labs, Urban Future Lab in New York, and Fraunhofer, headquartered in Michigan. C2V focuses on accelerating technology solutions that capture carbon dioxide for conversion into value-adding products and services.

Similar to the way a sponge is moistened and later wrung out, C-Quester pulls CO2 from flue gas into a temperature-sensitive material that can be heated later to release carbon, making the storage and transport of CO2 easier to manage.

Capture6 uses CO2 pulled from the atmosphere through their Direct Air Capture technology in combination with water treatment methodologies to remove excess salinity from saltwater and brine, resulting in greater freshwater recovery, usable elements for a variety of industries, and carbonates transformed into mineralized form to prevent continued carbon emissions.

Energy efficiency

The Helix MICRA filters created by Helix Earth Technologies can remove CO2 from power plants and other pollutants commonly encountered in the shipping industry. The filtering technology, initially developed for NASA, also dehumidifies air conditioning systems for more efficient energy use.

H2PRO uses its water-splitting technology, E-TAC, to produce green hydrogen in a two-step process that requires less energy to perform than the more common process of electrolysis with improved safety aspects.

Steam production and distribution get an upgrade with Imperium Technologies, the first electromechanical solution that enables previously unseen systems monitoring for reduction in greenhouse gas emissions by 20 percent, on average.

With a keen focus on predictive insights, eologix deploys smart sensors to give operators advance warning of situations that could cause rotor imbalances to keep wind turbines – and the energy they produce – optimized.

Resource accessibility

NW NA supports the goals of stability, predictability, and accessibility of electric-powered vehicle use with its high-power EV-charging station, mobile electricity storage units, and renewable energy measurement and forecasting tool.

From the Metaversity under development, to its oil and gas line leak detection systems, Kauel goes all-in on AI for its clients, even helping children with kinesthetic rehabilitation through augmented and virtual reality programs.

Finally, SkyH2O brings fresh, clean water to areas with limited access to existing infrastructure or natural water resources for commercial, military, and industrial use.

Another eight startups join the cohort named above as members of the Greentown Labs Boston location: Capro-X, Carbon2Stone, Cottage, Dioxycle, enaDyne, Global Algae Innovations, Terrafixing, and Thola.

------

This article originally ran on EnergyCapital.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.